The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Activation of PI3K Is Indispensable for Interleukin 7–mediated Viability, Proliferation, Glucose Use, and Growth of T Cell Acute Lymphoblastic Leukemia Cells
Open accessAbstract
Interleukin (IL)-7 is essential for normal T cell development. Previously, we have shown that IL-7 increases viability and proliferation of T cell acute lymphoblastic leukemia (T-ALL) cells by up-regulating Bcl-2 and down-regulating the cyclin-dependent kinase inhibitor p27kip1. Here, we examined the signaling pathways via which IL-7 mediates these effects. We investigated mitogen-activated protein kinase (MEK)–extracellular signal-regulated kinase (Erk) and phosphatidylinositol-3-kinase (PI3K)–Akt (protein kinase B) pathways, which have active roles in T cell expansion and have been implicated in tumorigenesis. IL-7 induced activation of the MEK–Erk pathway in T-ALL cells; however, inhibition of the MEK–Erk pathway by the use of the cell-permeable inhibitor PD98059, did not affect IL-7–mediated viability or cell cycle progression of leukemic cells. IL-7 induced PI3K-dependent phosphorylation of Akt and its downstream targets GSK-3, FOXO1, and FOXO3a. PI3K activation was mandatory for IL-7–mediated Bcl-2 up-regulation, p27kip1 down-regulation, Rb hyperphosphorylation, and consequent viability and cell cycle progression of T-ALL cells. PI3K signaling was also required for cell size increase, up-regulation of CD71, expression of the glucose transporter Glut1, uptake of glucose, and maintenance of mitochondrial integrity. Our results implicate PI3K as a major effector of IL-7–induced viability, metabolic activation, growth and proliferation of T-ALL cells, and suggest that PI3K and its downstream effectors may represent molecular targets for therapeutic intervention in T-ALL.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hengartner, M. O. (2000) · Nature · doi:10.1038/35037710 · Cited by 5,779
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594
Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked
Yang, J., Liu, X., Bhalla, K., Kim, C. N., Ibrado, A. M., Cai, J., Peng, T.-I., Jones, D. P., & Wang, X. (1997) · Science · doi:10.1126/science.275.5303.1129 · Cited by 4,911
The retinoblastoma protein and cell cycle control
Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862
Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization
Diehl, J. A., Cheng, M., Roussel, M. F., & Sherr, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.22.3499 · Cited by 2,130
Polyak, K., Lee, M.-H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P., & Massagué, J. (1994) · Cell · doi:10.1016/0092-8674(94)90572-x · Cited by 2,118
Cantley, L. C., & Neel, B. G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.8.4240 · Cited by 2,006
Interleukin-3-Induced Phosphorylation of BAD Through the Protein Kinase Akt
Peso, L. D., González-Garcı́a, M., Page, C., Herrera, R., & Nuñez, G. (1997) · Science · doi:10.1126/science.278.5338.687 · Cited by 1,797
MAP Kinases in the Immune Response
Dong, C., Davis, R. J., & Flavell, R. A. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.091301.131133 · Cited by 1,662
Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice.
Peschon, J. J., Morrissey, P. J., Grabstein, K. H., Ramsdell, F. J., Maraskovsky, E., Gliniak, B. C., Park, L. S., Ziegler, S. F., Williams, D. E., Ware, C. B., et al. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.5.1955 · Cited by 1,555
The CD28 Signaling Pathway Regulates Glucose Metabolism
Frauwirth, K. A., Riley, J. L., Harris, M. H., Parry, R. V., Rathmell, J. C., Plas, D. R., Elstrom, R. L., June, C. H., & Thompson, C. B. (2002) · Immunity · doi:10.1016/s1074-7613(02)00323-0 · Cited by 1,475
Protein Kinase C Isotypes Controlled by Phosphoinositide 3-Kinase Through the Protein Kinase PDK1
Le Good, J. A., Ziegler, W. H., Parekh, D. B., Alessi, D. R., Cohen, P., & Parker, P. J. (1998) · Science · doi:10.1126/science.281.5385.2042 · Cited by 1,110
Delcommenne, M., Tan, C., Gray, V., Rue, L., Woodgett, J., & Dedhar, S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.19.11211 · Cited by 1,092
The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal.
Kennedy, S. G., Wagner, A. J., Conzen, S. D., Jordán, J., Bellacosa, A., Tsichlis, P. N., & Hay, N. (1997) · Genes & Development · doi:10.1101/gad.11.6.701 · Cited by 1,074
Role of Glycogen Synthase Kinase-3 in the Phosphatidylinositol 3-Kinase/Akt Cell Survival Pathway
Pap, M., & Cooper, G. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.19929 · Cited by 1,040
Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency
Puel, A., Ziegler, S. F., Buckley, R. H., & Leonard., W. J. (1998) · Nature Genetics · doi:10.1038/3877 · Cited by 813
Chemistry and biology of eukaryotic iron metabolism
Aisen, P. (2001) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(01)00063-2 · Cited by 804
Nuclear Export of NF-ATc Enhanced by Glycogen Synthase Kinase-3
Beals, C. R., Sheridan, C. M., Turck, C. W., Gardner, P., & Crabtree, G. R. (1997) · Science · doi:10.1126/science.275.5308.1930 · Cited by 754
Dijkers, P. F., Medema, R. H., Pals, C., Banerji, L., Thomas, N. S. B., Lam, E. W.-F., Burgering, B. M. T., Raaijmakers, J. A. M., Lammers, J.-W. J., Koenderman, L., et al. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.24.9138-9148.2000 · Cited by 617
Petit, P. X., Lecoeur, H., Zorn, E., Dauguet, C., Mignotte, B., & Gougeon, M. L. (1995) · The Journal of cell biology · doi:10.1083/jcb.130.1.157 · Cited by 592
Akt Maintains Cell Size and Survival by Increasing mTOR-dependent Nutrient Uptake
Edinger, A. L., & Thompson, C. B. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.01-12-0584 · Cited by 589
Rathmell, J. C., Fox, C. J., Plas, D. R., Hammerman, P. S., Cinalli, R. M., & Thompson, C. B. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.20.7315-7328.2003 · Cited by 572 · cited 1×
“In mature T cells, the PI3K–Akt pathway regulates glucose metabolism mediated by CD28 costimulation (28), and Akt-controlled glucose uptake can promote survival and cell growth in other cell types (30, 58).”
BackgroundProposals for immunological classification of acute leukemias.
van Dongen, J. J. M. (1995) · PubMed · Cited by 543
Growth factors can influence cell growth and survival through effects on glucose metabolism
Vander Heiden, M. G., Plas, D. R., Rathmell, J. C., Fox, C. J., Harris, M. H., & Thompson, C. B. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.17.5899-5912.2001 · Cited by 536
Rathmell, J. C., Heiden, M. G. V., Harris, M. H., Frauwirth, K. A., & Thompson, C. B. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00066-6 · Cited by 467
IL-7 Enhances the Survival and Maintains the Size of Naive T Cells
Rathmell, J. C., Farkash, E. A., Gao, W., & Thompson, C. B. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.12.6869 · Cited by 459
Transformation of Chicken Cells by the Gene Encoding the Catalytic Subunit of PI 3-Kinase
Chang, H. W., Aoki, M., Fruman, D., Auger, K. R., Bellacosa, A., Tsichlis, P. N., Cantley, L. C., Roberts, T. M., & Vogt, P. K. (1997) · Science · doi:10.1126/science.276.5320.1848 · Cited by 412
Selective requirement for MAP kinase activation in thymocyte differentiation
Alberola-lla, J., Forbush, K. A., Seger, R., Krebs, E. G., & Perlmutter, R. M. (1995) · Nature · doi:10.1038/373620a0 · Cited by 389
Regulation of Bad Phosphorylation and Association with Bcl-xL by the MAPK/Erk Kinase
Scheid, M. P., Schubert, K. M., & Duronio, V. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.43.31108 · Cited by 384
Sawadogo, D., Tolo, A., Kassi, H., Sangare, M., & Inwoley, A. (2013) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2013.023 · Cited by 381
von Freeden-Jeffry, U., Solvason, N., Howard, M., & Murray, R. (1997) · Immunity · doi:10.1016/s1074-7613(00)80517-8 · Cited by 332
Cell cycle targets of Ras/Raf signalling
Kerkhoff, E., & Rapp, U. R. (1998) · Oncogene · doi:10.1038/sj.onc.1202185 · Cited by 260
Klippel, A., Escobedo, M.-A., Wachowicz, M. S., Apell, G., Brown, T. W., Giedlin, M. A., Kavanaugh, W. M., & Williams, L. T. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.10.5699 · Cited by 258
Cutaneous lymphoproliferation and lymphomas in interleukin 7 transgenic mice.
Rich, B. E., Campos-Torres, J., Tepper, R. I., Moreadith, R. W., & Leder, P. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.2.305 · Cited by 244
Pallard, C., Stegmann, A. P. A., van Kleffens, T., Smart, F., Venkitaraman, A., & Spits, H. (1999) · Immunity · doi:10.1016/s1074-7613(00)80052-7 · Cited by 204
Appleman, L. J., Berezovskaya, A., Grass, I., & Boussiotis, V. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.144 · Cited by 203
Self-citationAppleman, L. J., van Puijenbroek, A. A. F. L., Shu, K. M., Nadler, L. M., & Boussiotis, V. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.6.2729 · Cited by 201
Self-citationMyc-enhanced expression of Cul1 promotes ubiquitin-dependent proteolysis and cell cycle progression
O'Hagan, R. C., Ohh, M., David, G., de Alboran, I. M., Alt, F. W., Kaelin, W. G., & DePinho, R. A. (2000) · Genes & Development · doi:10.1101/gad.827200 · Cited by 194
Barata, J. T., Cardoso, A. A., Nadler, L. M., & Boussiotis, V. A. (2001) · Blood · doi:10.1182/blood.v98.5.1524 · Cited by 173
Self-citationYu, Q., Erman, B., Bhandoola, A., Sharrow, S. O., & Singer, A. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021765 · Cited by 169
Takuwa, N., & Takuwa, Y. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5348 · Cited by 166
Glycogen Synthase Kinase-3 Inhibits the DNA Binding Activity of NFATc
Neal, J. W., & Clipstone, N. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004888200 · Cited by 163
Chakrabarti, R., Jung, C. Y., Lee, T. P., Liu, H., & Mookerjee, B. K. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.6.2660 · Cited by 149
PI 3-K and T-cell activation: limitations of T-leukemic cell lines as signaling models
Astoul, E. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)01973-1 · Cited by 135
Why size matters: altering cell size
Saucedo, L. J., & Edgar, B. A. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00341-6 · Cited by 134
Protein kinase B (Akt) regulation and function in T lymphocytes
Cantrell, D. A. (2002) · Seminars in Immunology · doi:10.1006/smim.2001.0338 · Cited by 124
Oosterwegel, M. A., Haks, M. C., Jeffry, U. B., Murray, R., & Kruisbeek, A. M. (1997) · Immunity · doi:10.1016/s1074-7613(00)80337-4 · Cited by 113
Apoptosis is regulated by the rate of glucose transport in an interleukin 3 dependent cell line.
Kan, O., Baldwin, S. A., & Whetton, A. D. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.180.3.917 · Cited by 110
Smith, E., Coetzee, G. A., & Frenkel, B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109708200 · Cited by 102
Malstrom, S. E., Tili, E., Kappes, D. J., Ceci, J. D., & Tsichlis, P. N. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231467698 · Cited by 93
Karawajew, L., Ruppert, V., Wuchter, C., Kösser, A., Schrappe, M., Dörken, B., & Ludwig, W.-D. (2000) · Blood · doi:10.1182/blood.v96.1.297 · Cited by 87
Sharfe, N., Dadi, H., & Roifman, C. M. (1995) · Blood · doi:10.1182/blood.v86.6.2077.bloodjournal8662077 · Cited by 80
Funk, P. E., Stephan, R., & Witte, P. (1995) · Blood · doi:10.1182/blood.v86.7.2661.2661 · Cited by 74
Hare, K. J., Jenkinson, E. J., & Anderson, G. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2410 · Cited by 72
Dıbırdık, İ., Chandan-Langlie, M., Ledbetter, J. A., Tuel-ahlgren, L., Obuz, V., Waddick, K., Gajl-Peczalska, K., Schieven, G. L., & Uckun, F. M. (1991) · Blood · doi:10.1182/blood.v78.3.564.564 · Cited by 70
Uckun, F. M., Tuel-ahlgren, L., Obuz, V., Smith, R. J., Dıbırdık, İ., Hanson, M., Langlie, M. C., & Ledbetter, J. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.14.6323 · Cited by 62
Interleukin‐7 induces T cell proliferation in the absence of Erk/MAP kinase activity
Crawley, J. B., Willcocks, J., & Foxwell, B. M. J. (1996) · European Journal of Immunology · doi:10.1002/eji.1830261125 · Cited by 51
IL-7–dependent human leukemia T-cell line as a valuable tool for drug discovery in T-ALL
Barata, J. T., Boussiotis, V. A., Yunes, J. A., Ferrando, A. A., Moreau, L. A., Veiga, J. P., Sallan, S. E., Look, A. T., Nadler, L. M., & Cardoso, A. A. (2003) · Blood · doi:10.1182/blood-2002-12-3861 · Cited by 47
Self-citationOverexpression of IL-7Rα provides a competitive advantage during early T-cell development
Laouar, Y., Crispe, I., & Flavell, R. (2004) · Blood · doi:10.1182/blood-2003-06-2126 · Cited by 42
Scupoli, M. T., Vinante, F., Krampera, M., Vincenzi, C., Nadali, G., Zampieri, F., Ritter, M. A., Eren, E., Santini, F., & Pizzolo, G. (2003) · PubMed · Cited by 38
Cited by
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
Metabolic Regulation of T Lymphocytes
MacIver, N. J., Michalek, R. D., & Rathmell, J. C. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095956 · Cited by 1,244
Patsoukis, N., Bardhan, K., Chatterjee, P., Sari, D., Liu, B., Bell, L. N., Karoly, E. D., Freeman, G. J., Petkova, V., Seth, P., et al. (2015) · Nature Communications · doi:10.1038/ncomms7692 · Cited by 1,202
Self-citationMetabolic regulation of immune responses
Ganeshan, K., & Chawla, A. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120236 · Cited by 926
“This increase in Glut1 expression and glucose uptake occurs in a PI3K/Akt dependent manner, allowing cells to maintain their mitochondrial potential and ATP homeostasis (84, 85) (Figure 4).”
BackgroundMaurer, U., Charvet, C., Wagman, A. S., Dejardin, E., & Green, D. R. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.02.009 · Cited by 881
Metadata
- Authors
- Barata, J. T., Silva, A., Brandao, J. G., Nadler, L. M., Cardoso, A. A., & Boussiotis, V. A.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2004-09-06
- Volume
- 200
- Issue
- 5
- Pages
- 659-669
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2149627687
- Cited by
- 284
- References
- 60
- FWCI
- 8.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.